Claritev Corp
For the period ended Mar 31, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 7, 2026
CTEV$28.67+19.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets (unaudited)
(in thousands, except share and per share data)
| March 31, 2026 | December 31, 2025 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $21,327 | $16,814 |
| Restricted cash | 13,401 | 11,527 |
| Trade accounts receivable, net | 140,917 | 127,615 |
| Prepaid expenses | 35,349 | 31,992 |
| Prepaid taxes | 4,101 | 11,526 |
| Unbilled Independent Dispute Resolution fees, net | 13,304 | 10,563 |
| Other current assets, net | 13,868 | 14,330 |
| Total current assets | 242,267 | 224,367 |
| Property and equipment, net | 343,599 | 326,326 |
| Operating lease right-of-use assets | 13,549 | 13,966 |
| Goodwill | 2,405,853 | 2,405,853 |
| Other intangibles, net | 1,798,696 | 1,884,604 |
| Other assets, net | 35,335 | 33,342 |
| Total assets | $4,839,299 | $4,888,458 |
| Liabilities and Shareholders’ Deficit | ||
| Current liabilities: | ||
| Accounts payable | $59,176 | $60,463 |
| Accrued interest | 52,277 | 100,009 |
| Operating lease obligation, short-term | 4,907 | 4,705 |
| Current portion of long-term debt | 14,690 | 14,690 |
| Accrued compensation | 19,672 | 45,238 |
| Other accrued expenses | 38,842 | 36,253 |
| Total current liabilities | 189,564 | 261,358 |
| Long-term debt | 4,574,253 | 4,560,440 |
| 2025 Revolving Credit Facility | 125,000 | 20,000 |
| Operating lease obligation, long-term | 15,060 | 16,236 |
| Deferred income taxes | 169,836 | 197,599 |
| Total liabilities | 5,073,713 | 5,055,633 |
| Commitments and contingencies (Note 7) | ||
| Shareholders’ deficit: | ||
| Shareholder interests | ||
| Preferred stock, $0.0001 par value — 10,000,000 shares authorized; no shares issued | — | — |
| Common stock, $0.0001 par value — 1,500,000,000 shares authorized; 17,743,149 and 17,295,582 issued; 17,000,290 and 16,552,723 shares outstanding as of March 31, 2026 and December 31, 2025, respectively | 2 | 2 |
| Additional paid-in capital | 2,402,923 | 2,398,423 |
| Accumulated deficit | (2,502,980) | (2,429,420) |
| Accumulated other comprehensive loss | (2,351) | (4,172) |
| Treasury stock - 742,859 shares as of March 31, 2026 and December 31, 2025 | (138,733) | (138,733) |
| Total shareholders’ (deficit)/equity attributable to Claritev Corporation | (241,139) | (173,900) |
| Non-controlling interests | 6,725 | 6,725 |
| Total shareholders' deficit | (234,414) | (167,175) |
| Total liabilities and shareholders’ deficit | $4,839,299 | $4,888,458 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.